DBV Technologies | DBVT - Ativo Circulante





Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amarin USD 602.76M 23.26M 2026-06
BioCryst Pharmaceuticals USD 373.62M 30.72M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
DBV Technologies USD 201.9M 44.8M 2026-06
Galectin Therapeutics USD 27.29M 1.83M 2024-06
Halozyme Therapeutics USD 1B 177.83M 2026-03
Incyte USD 6.03B 542.31M 2026-06
Insmed USD 1.61B 181.04M 2026-03
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
PTC Therapeutics USD 2.62B 363.36M 2026-06
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
United Therapeutics USD 2.87B 830.5M 2026-03